THE DEAL, AT A GLANCE
From the announcementExpedition Therapeutics
01Who is involvedBacked by General Atlantic, RA Capital, Vivo Capital, Sofinnova InvestmentsFrom the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗02What happenedExpedition Therapeutics raised $115M Series B, announced 2026-08-05From the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗03Why it mattersExpedition Therapeutics raised an oversubscribed Series B to advance a next-generation DPP1 inhibitor for COPD and expand its DPP1 inhibitor pipeline into other…From the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗Click a part to explore its evidence. Unsupported imagery is withheld rather than guessed.Original record source ↗
Expedition Therapeutics · Financing Record
Explore source-linked visual explanations for Expedition Therapeutics. Unsupported claims are withheld while source review continues.
Record 9711 · Recorded date: 2026-08-05
Explore company records →